Promega Hosts Fight Colorectal Cancer (Fight CRC) Research Advocacy Training and Support (RATS) Program

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites.
Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. For avoidance of any doubts and to make it easier, you may consider any links to external websites as sponsored links. Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Promega Corporation this week is hosting a hands-on research academy for colorectal cancer survivors, caregivers and other members of the Fight Colorectal Cancer (Fight CRC) Research Advocacy Training and Support (RATS) program. RATS advocates are volunteers from around the country who train to gain a comprehensive understanding of basic science, as well as clinical and diagnostic research in colorectal cancer and related diseases, so they can be empowered to work for the advancement of cancer research in new and innovative ways.

During the two-day interactive training event on the Promega Madison campus, participants will have the unique opportunity to engage in lab activities with Promega scientists while learning about topics such as:

  • molecular oncology workflow
  • genomic analysis for cancer
  • bioluminescence and drug discovery
  • immunotherapy and hereditary cancer risk
  • microsatellite instability (MSI)

Special guest Stacy Hurt, an accomplished executive in the healthcare industry, will also share lessons she learned while overcoming stage IV colorectal cancer.

Were excited about this opportunity to work alongside advocates for colorectal cancer research in our Promega labs to offer them an up-close, hands-on perspective of the research process and learn from each of their particular experiences as well, says Heather Tomlinson, Director of Clinical Diagnostics at Promega We are especially eager to share our insight of the role inherited genetic conditions such as Lynch syndrome plays in increasing the likelihood of developing colorectal and other types of cancer, and how simple screening tests performed on cancerous tumor tissue can determine if Lynch syndrome is likely.

This is the first Fight CRC RATS research academy Promega has hosted and is a continuation of the companys commitment, announced in March for Colorectal Cancer Awareness month and National Lynch Syndrome Awareness Day (March 22), to advance colorectal cancer education.

Learn more about Promega support of colorectal cancer research at

About Promega

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The companys 4,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, drug discovery and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information about Promega, visit

Contact: Penny Patterson

VP, Communications

Promega Corporation

Phone: (608) 274-4330

E-mail: [email protected]